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ABSTRACT
Objective To examine patterns of colorectal cancer
(CRC) screening uptake over three biennial invitation
rounds in the National Health Service (NHS) Bowel
Cancer Screening Programme (BCSP) in England.
Methods We analysed data from the BCSP’s Southern
Hub for individuals (n=62 099) aged 60–64 years at the
time of ﬁrst invitation to screening with a follow-up
period that allowed for two further biennial invitations.
Data on sex, age and a neighbourhood-level measure of
socioeconomic deprivation were used in the analysis.
Outcomes included uptake of guaiac-based faecal occult
blood (gFOB) test screening, inadequate gFOB screening
(≥1 test kit(s) returned but failed to complete further
gFOB tests needed to reach a conclusive test result), test
positivity, compliance with follow-up examinations
(usually colonoscopy) and diagnostic outcomes.
Results Overall gFOB uptake was 57.4% in the ﬁrst,
60.9% in the second and 66.2% in third biennial
invitation round. This resulted in 70.1% of the initial
cohort having responded at least once, 60.7% at least
twice and 44.4% three times. Participation in the ﬁrst
round was strongly predictive of participation in the
second round (‘Previous Responders’: 86.6% vs
‘Previous Non-Responders’: 23.1%). Participation in the
third round was highest among ‘Consistent Screeners’
(94.5%), followed by ‘Late Entrants’ (78.0%), ‘Dropouts’
(59.8%) and ‘Consistent Non-Responders’ (14.6%).
Socioeconomic inequalities in uptake were observed
across the three rounds, but sex inequalities decreased
over rounds. Inadequate gFOB screening was inﬂuenced
by screening history and socioeconomic deprivation.
Screening history was the only signiﬁcant predictor of
follow-up compliance.
Conclusions Screening history is associated with
overall gFOB uptake, inadequate gFOB screening and
follow-up compliance. Socioeconomic deprivation is also
consistently associated with lower gFOB uptake and
inadequate gFOB screening. Improving regular screening
among identiﬁed ‘at-risk’ groups is important for the
effectiveness of CRC screening programmes.
INTRODUCTION
Colorectal cancer (CRC) is the second highest
cause of cancer deaths in developed countries.1
Trials have shown that CRC screening using a
guaiac-based faecal occult blood (gFOB) test
reduces CRC mortality by up to 25% among those
who participate.2 3 In England, CRC screening is
organised through the National Health Service
(NHS) Bowel Cancer Screening Programme
(BCSP), and all adults aged 60–74 years (inclusive)
are invited to complete a gFOB test every 2 years.
The programme was launched in 2006, and screen-
ing to the 60–69-year age group was available in all
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Signiﬁcance of this study
What is already known on this subject?
▸ There are strong sex and socioeconomic
inequalities in colorectal cancer (CRC) screening
uptake.
▸ Screening history is strongly associated with
subsequent CRC uptake.
▸ Repeated invitations to screening successfully
engage previous non-responders.
▸ While many respond to at least one screening
invitation over multiple invitation rounds, a
considerably smaller number respond
consistently to all invitations.
What are the new ﬁndings?
▸ Dropout in the second biennial invitation round
following a screen in the ﬁrst round is
associated with lower uptake in the third round
than delayed prevalence screening in the
second round.
▸ Socioeconomic inequalities in uptake persist,
while sex inequalities decrease over three
invitation rounds.
▸ An irregular screening history and
socioeconomic deprivation are associated with
inadequate gFOB screening (failing to complete
multiple gFOB test kits needed to reach a
conclusive test result).
▸ Screening history is predictive of compliance
with follow-up examinations (usually
colonoscopy).
How might it impact on clinical practice in
the foreseeable future?
▸ An irregular screening history and
socioeconomic deprivation are risk factors of
non-compliance at various stages in the CRC
screening process.
▸ Efforts to increase (continued) engagement
among these ‘at-risk’ groups are important to
optimise the long-term impact of organised
screening programmes.
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areas by 2010, and by March 2014 it was available to those
aged up to and including 74 years in all but two areas. The
average, overall uptake of screening has been around 54%.4
Socioeconomic deprivation is strongly associated with uptake,
which ranges from 35% in the most deprived quintile to 61%
in the most afﬂuent quintile,4 and women are also more likely
to take part than men.5
Invitations to screening are sent to all age-eligible adults every
2 years, irrespective of screening history (ie, previous screening
participation). ‘Prevalence screening’ is the term commonly used
to describe ﬁrst-time screening, and ‘incidence screening’ for
screening of subjects who have been screened on a previous
occasion. Studies have shown that repeated invitations to screen-
ing can successfully engage a substantial number of previous
non-responders. English and Scottish demonstration pilots
achieved uptake of 14–15% at the second, and 10% at the third
invitation to prevalence screening.5 6 However, only a minority
of subjects in Scottish and Italian pilots consistently responded
over multiple biennial invitations rounds.7 8
The English pilot data also suggest that socioeconomic
inequalities in uptake of screening invitations persist over time,
although sex differences decreased.5 The English pilot investiga-
tors combined data from prevalence and incidence screens
however, and any association between uptake and screening
history was not investigated. We also do not know whether
some groups are less resilient in overcoming potential obstacles
within a screening episode. The need to repeat gFOB tests, or to
refer participants for follow-up investigations after an abnormal
gFOB test result, can lead to incomplete screening and might
have a disproportionately discouraging effect among the
‘hard-to-reach’ population, such as men and individuals from
deprived backgrounds.
Screening history and known sociodemographic inequalities
in uptake need to be considered in order to understand CRC
screening uptake over time and over successive screening invita-
tion rounds. This study examines the effects that screening
history, socioeconomic deprivation, and sex might have on CRC
screening uptake over three biennial invitation rounds in the
BCSP in England.
METHODS
Colorectal cancer screening in England
The NHS in England operates an organised CRC screening pro-
gramme with a comprehensive call and recall system. All adults
in England who are aged 60–74 years (inclusive) and are regis-
tered with a general practitioner (GP) are invited by the NHS
BCSP to biennial CRC screening using a gFOB test kit. Primary
care providers are not involved with the invitation process. A
preinvitation letter including an information leaﬂet is ﬁrst sent
by one of ﬁve Screening Hubs. A test kit, spatula, instruction
leaﬂet and freepost return envelope are sent about 8 days later,
unless requested not to do so by the invited subject. Subjects
who do not respond to the screening invitation are sent a
reminder 28 days after mailing the test kit. The test kit used by
the BCSP in England (hema-screen, Immunostics, USA) has
three paired windows. Two faecal samples from three consecu-
tive stools are applied to each of the six windows in turn. In the
laboratory, each window is tested for the presence of blood.
Participants with ﬁve or six positive windows (a strong positive
or ‘abnormal’ result) are offered an appointment with a special-
ist screening practitioner (SSP) to discuss further investigation,
usually colonoscopy. If a participant has only one, two, three or
four positive windows (a weak positive or an ‘unclear’ result)
the participant is asked to complete another test kit. If the
second test kit is negative (no positive windows), a third test kit
is requested and if the third test kit is negative, the subject is
returned to routine biennial screening. If any windows on a
second or third test kit are positive (‘abnormal’ result), an
appointment with an SSP is arranged. When a test kit is desig-
nated ‘spoilt’ (ie, inadequate or undated sample collection) or
‘technically failed’ (ie, laboratory-based reading error) a further
test kit is mailed to the subject within the same screening round.
Sample
This study used anonymised data from the Bowel Cancer
Screening Southern Programme Hub. The Hub is responsible
for the biennial screening of all 60–74-year-old subjects in
southern England (excluding London), and invites approxi-
mately 1.1 million subjects annually.
Data were extracted from the Bowel Cancer Screening System
(BCSS) for all subjects (n=62 099) who, at the time of their ﬁrst
screening invitation, were aged 60–64 years between September
2006 and February 2008. The speciﬁed age range ensured that,
for the period of the study, all subjects were eligible for three
biennial screening invitation rounds. The term ‘round’ describes
a cohort of subjects invited to be screened, and ‘three biennial
invitation rounds’ refers to a cohort of subjects who have
received a third invitation to be screened having received two
previous invitations (at two-yearly intervals) in which they may,
or may not, have chosen to participate.
Screening activity was recorded until December 2012 to
allow a minimum of 3 months for subject response, possible
follow-up investigations and changes to invitation dates made by
the Hub to minimise ﬂuctuations in referred colonoscopy work-
load (‘invitation smoothing’).9
Within the identiﬁed population, some subjects did not
receive three biennial screening invitations because of on-going
surveillance for polyps/adenomas, a signiﬁcant medical condi-
tion including cancer, relocation outside the catchment area of
the Hub, a written request declining any further screening invi-
tations or due to the death of the subject. Those who inform
the Hub that they wish to ‘opt-out’ of their current biennial
screening round are routinely reinvited in 2 years’ time, unless
they complete an ‘Informed Dissent Ceasing’ form.
Measures
For each of the three biennial invitation rounds examined in
this study, the following was recorded: if and when each subject
was sent an invitation for gFOB test screening, whether they
had been adequately screened (deﬁnitive gFOB test result), the
screening test result if adequately screened (negative or positive),
and the number of test kits completed by each participant
within each screening round. The following were derived from
the screening date: percentage of participants requiring only
one test kit within one screening round (number adequately
screened from 1 test kit/number completed ≥1 test kit(s),
adequately or inadequately screened), the percentage of partici-
pants who required multiple test kits within one screening
episode (100% -% requiring one test kit only), and the percent-
age of subjects who were inadequately screened due to failure to
complete the number of test kits required to reach a deﬁnitive
result (number completed ≥1 test kit and not adequately
screened/number completed ≥1 test kit, adequately or inad-
equately screened).
For participants who had received a positive (abnormal) test
result, attendance at the SSP appointment and compliance with
follow-up (colonoscopy or another follow-up examination) was
recorded. A single dichotomous variable for follow-up
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compliance was created and deﬁned as failure to attend either
SSP OR colonoscopy/other follow-up examination (0) and
attendance of SSP AND colonoscopy/other follow-up examin-
ation (1). For those who had undergone follow-up examina-
tions, the diagnostic outcome of the follow-up investigation was
also recorded. Colonoscopy is the default follow-up investiga-
tion in the BCSP, but alternative investigations, such as CT colo-
nography (CTC), ﬂexible sigmoidoscopy or rarely, barium
enema, are offered if colonoscopy is deemed unsuitable.
Diagnostic outcome categories included CRC, high-risk or
intermediate-risk adenomas (at least 3–4 adenomas of <1 cm or
one >1 cm), low-risk adenomas (1–2 adenomas of <1 cm)10
and ‘other abnormal ﬁndings’ (eg, Crohn’s disease, ulcerative
colitis and diverticulitis).
Sex and age at the time of invitation, and an area-level measure
of socioeconomic deprivation (Index of Multiple Deprivation
(IMD) score) were also recorded for each invited subject. The
IMD score uses 2001 census-derived indicators of income, edu-
cation, employment, environment, health and housing for each
individual’s residential postcode sector to create a scale from 0
(least deprived) to 80 (most deprived).11 The IMD score was
used for regression analyses. For illustrative purposes, IMD quin-
tiles were generated using the IMD scores of the total population
included in the dataset. The average age was 61.8 years at the
ﬁrst, 64.0 at the second, and 66.0 at the third invitation round.
Age was categorised into three groups for each invitation round.
The ﬁrst two age categories consist of a 2-year timespan,
whereas, the third category comprises all older ages.
Late completion of test kits, delays due to follow-up investiga-
tions or Hub invitation smoothing practices, caused some sub-
jects to receive invitations signiﬁcantly longer than 2 years after
a previous invitation.
We also coded a variable denoting uptake in previous invita-
tion rounds. Table 1 describes the resulting subgroups by screen-
ing history in the second and third biennial invitation rounds.
Data analysis
gFOB uptake of screening invitations (ie, adequately screened),
inadequate gFOB screening, test positivity, follow-up compli-
ance and diagnostic outcomes are described for each invitation
round. Multivariable logistic regression analysis was used to
examine the effects of screening history and sociodemographics
on uptake for each invitation round, inadequately screening and
follow-up compliance. Multivariable logistic regression was also
used to test for sociodemographic effects on uptake in each of
the screening history subgroups in the second and third biennial
invitation rounds. Two-sample tests of proportions were used to
test for differences between invitation rounds or between
screening history subgroups in uptake, inadequate screening, test
positivity, follow-up compliance and diagnostic outcomes.
RESULTS
gFOB uptake over three biennial invitation rounds
Of the subjects ﬁrst invited between September 2006 and
February 2008, overall gFOB uptake was 57.4% in the ﬁrst,
60.9% in the second (p<0.001), and 66.2% in the third
(p<0.001) biennial invitation rounds (table 2). This resulted in
43 511 (70.1%) subjects in the initial cohort having responded
at least once, 37 667(60.7%) at least twice and 27 587 (44.4%)
three times after three invitation rounds. The number of invita-
tions and uptake over the three biennial invitation rounds by
response to previous invitations are presented in ﬁgure 1.
Screening history was strongly associated with subsequent
uptake in the second and third biennial invitation rounds, and
will be discussed for each invitation round below.
The difference in uptake between women and men was great-
est in the ﬁrst biennial invitation round (61.3% vs 53.3%,
OR=0.72, 95% CI 0.70 to 0.74, p<0.001), and less in the
second (63.7% vs 58.0%, OR=0.93, 95% CI 0.89 to 0.97,
p<0.01) and third round (68.2% vs 64.1%, OR=1.05, 95% CI
0.99 to 1.10, ns.; table 3). A gradient in uptake by socio-
economic deprivation was observed in all three rounds (1st
round: ∼14.2% difference between the lowest and highest quin-
tile, OR=0.98, 95% CI 0.98 to 0.98, p<0.001; 2nd round:
∼16.0%, OR=0.98, 95% CI 0.98 to 0.99, p<0.001; 3rd
round: ∼16.4%, OR=0.99, 95% CI 0.98 to 0.99, p<0.001).
There was little difference in uptake between the age groups.
Second biennial invitation round gFOB uptake by screening
history
As stated earlier, overall uptake was 60.9% in the second bien-
nial invitation round (table 2). Of the ‘Previous Responders’
who were reinvited, 86.6% responded to the second invitation,
whereas, only 23.1% of ‘Previous Non-Responders’ responded
to a second invitation (p<0.001; table 4).
Socioeconomic and sex effects were observed among
‘Previous Responders’ and ‘Previous Non-Responders’ alike, and
were similar to the overall results for the second invitation
round. The older age subjects showed signiﬁcantly higher
uptake among ‘Previous Non-Responders’ (62–63: 22.3%, ref;
64–65: 23.6%, OR=1.07, 95% CI 1.00 to 1.14, p<0.05; 66+:
25.2%, OR=1.18, 95% CI 1.05 to 1.32, p<0.01), but not
among ‘Previous Responders’ (table 5).
Third biennial invitation round gFOB uptake by screening
history
Overall uptake was 70.1% in the third biennial invitation
round, as discussed previously (table 2). An overwhelming
94.5% of those who had responded to the ﬁrst two biennial
invitations (‘Consistent Screeners’) also responded to a third
invitation (table 6). Among those who had not responded in the
Table 1 Screening history of subgroups in the second and third biennial invitation rounds
Previous uptake in 1st round Previous uptake in 2nd round Description
Subgroups in 2nd round
Previous Responders Screened – 1st invitation to 1st incidence screening
Previous Non-Responders Not screened – 2nd prevalence screening invitation
Subgroups in 3rd round
Consistent Screeners Screened Screened 1st invitation to 2nd incidence screening
Late Entrants Not screened Screened 1st invitation to 1st incidence screening
Dropouts Screened Not screened 2nd invitation to 1st incidence screening
Consistent Non-Responders Not screened Not screened 3rd prevalence screening invitation
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ﬁrst but had participated in the second round (‘Late Entrants’),
78.0% responded to the third invitation. Of those who had
responded in the ﬁrst but not in the second round (‘Dropouts’),
59.8% responded to the third invitation; 14.6% of those who
had not responded to the two previous invitations (‘Consistent
Non-Responders’) participated in the third round.
Socioeconomic deprivation was associated with lower uptake
in all four screening history subgroups in the third invitation
round (table 7). Sex differences were not signiﬁcant among
‘Consistent Screeners’, ‘Late Entrants’ and ‘Dropouts’. Age
effects were also not signiﬁcant in any subgroup. However,
among ‘Consistent Non-Responders’, men were more likely
than women to respond to a third prevalence screening invita-
tion (13.8% vs 15.3%, OR=1.14, 95% CI 1.04 to 1.24,
p<0.01), suggesting that repeated biennial prevalence screening
invitations reduce sex inequalities in screening uptake.
Additionally, older age was negatively associated with uptake
among ‘Consistent Non-Responders’ (64–65: 15.3%, ref; 66–
67: 14.1%, OR=0.91, 95% CI 0.83 to 1.00, p<0.05; 68+:
12.6%, OR=1.18, 95% CI 0.67 to 0.96, p<0.05). In conjunc-
tion with the positive effect of age on uptake among ‘Previous
Non-Responders’ in the second invitation round, these ﬁndings
imply a non-linear effect of age on prevalence screening uptake.
Inadequate gFOB screening
The vast majority of participants were required to return only one
test kit in order to reach a deﬁnitive test result. This proportion
was slightly lower in the second (94.6%, p<0.001) and third
(94.1%, p<0.001) biennial invitation round than in the ﬁrst
round (96.0%; table 2). Inadequate screening was rare (∼0.4%)
and its occurrence did not differ signiﬁcantly between the rounds.
Multivariable logistic regression analysis showed that socio-
economic deprivation was the only signiﬁcant sociodemographic
predictor of inadequate screening in the ﬁrst invitation round
(OR=1.03, 95% CI 1.02 to 1.05, p<0.001; table 8). This cor-
responded to 0.2% in the most afﬂuent quintile being inad-
equately screened compared with 0.8% of those in the most
deprived quintile (ﬁgures not shown in table). Multivariable
logistic regression results for the second and third rounds were
similar to those for the ﬁrst round.
Within the second invitation round, ‘Previous Responders’
were more likely to reach a deﬁnitive test result with only one
Table 2 Uptake per biennial screening invitation round by sociodemographics and other outcomes in percentages with the denominator (n)
1st Biennial invitation round 2nd Biennial invitation round 3rd Biennial invitation round
gFOB uptake
Total 57.35 (62 099) 60.88 (58 548)†*** 66.17 (55 038)†***/‡***
Women 61.34 (31 136) 63.69 (29 735) 68.18 (28 318)
Men 53.33 (30 963) 57.98 (28 813) 64.05 (26 720)
IMD 1st quintile§ 62.21 (12 489) 66.92 (11 902) 72.01 (11 268)
IMD 2nd quintile 61.23 (12 386) 64.22 (11 736) 70.26 (11 060)
IMD 3rd quintile 59.79 (12 386) 63.09 (11 725) 68.42 (11 072)
IMD 4th quintile 55.52 (12 394) 59.03 (11 658) 64.08 (10 951)
IMD 5th quintile 48.00 (12 406) 50.92 (11 500) 55.59 (10 665)
Age 60–61 at 1st invitation 56.73 (32 290) – –
Age 62–63 at 1st invitation 58.02 (25 143) – –
Age 64 at 1st invitation 57.99 (4666) – –
Age 62–63 at 2nd invitation¶ – 60.04 (30 203) –
Age 64–65 at 2nd invitation – 61.82 (23 709) –
Age 66+ at 2nd invitation – 61.57 (4635) –
Age 64–65 at 3rd invitation†† – – 65.85 (28 489)
Age 66–67 at 3rd invitation – – 66.66 (22 277)
Age 68+ at 3rd invitation – – 65.80 (4272)
Multiple gFOB testing
% Requiring one test only 95.96 (35 749) 94.56 (35 773)†*** 94.10 (36 552)†***/‡**
% Requiring multiple test kits 4.04 (35 749) 5.44 (35 773) 5.90 (36 552)
% Inadequately screened 0.39 (35 749) 0.36 (35 773)† 0.36 (36 552)†/‡
FOB positivity
Total 1.19 (35 611) 1.66 (35 645)†*** 1.94 (36 420)†***/n**
Follow-up compliance
Total 88.94 (425) 88.87 (593)† 87.54 (706)†/‡
Diagnostic outcomes
Cancers 10.85 (378) 8.35 (527)† 7.12 (618)†*/‡
High-risk and intermediate-risk adenomas 34.13 (378) 27.32 (527)†* 22.17 (618)†***/‡*
Low-risk adenomas 18.52 (378) 18.41 (527)† 16.34 (618)†
Other abnormal findings 8.20 (378) 15.37 (527)†** 32.04 (618)†***/‡***
* p<0.05; ** p<0.01; *** p<0.001.
†Compared with 1st biennial invitation.
‡Compared with 2nd biennial invitation.
§IMD scores were not available for 38 individuals.
¶Includes 61-year-olds turning 62 in the same month (n=1), age missing for n=1.
††Includes 63-year-olds turning 64 in the same month (n=3).
gFOB, guaiac-based faecal occult blood; IMD, Index of Multiple Deprivation.
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Figure 1 sample sizes in each biennial invitation round by previous uptake (in percentages of the total sample).
Table 3 Multivariable logistic regression results of gFOB uptake by biennial screening invitation round
1st Biennial invitation round
(n=62 061)
2nd Biennial invitation round
(n=58 20)
3rd Biennial invitation round
(n=55 016)
OR 95% CI OR 95% CI OR 95% CI
Sociodemographics
Women 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
Men 0.72*** 0.70 to 0.74 0.93** 0.89 to 0.97 1.05 0.99 to 1.10
IMD score (0–80) 0.98*** 0.98 to 0.98 0.98*** 0.98 to 0.99 0.99*** 0.98 to 0.99
Age at 1st invitation (60–64)
Age 60–61 1.00 (ref) – –
Age 62–63 1.05** 1.01 to 1.08 – –
Age 64 1.07* 1.01 to 1.14 – –
Age at 2nd invitation (62–70)
Age 62–63† – 1.00 (ref) –
Age 64–65 – 1.06** 1.02 to 1.12 –
Age 66+ – 1.08 0.99 to 1.17 –
Age at 3rd invitation (63–72)
Age 64–65‡ – – 1.00 (ref)
Age 66–67 – – 0.93*** 0.88 to 0.99
Age 68+ – – 0.83*** 0.75 to 0.92
Previous uptake pattern
Previous uptake patterns at 2nd invitation
Previous Responders – 1.00 (ref) –
Previous Non-Responders – 0.05*** 0.05 to 0.05 –
Previous uptake patterns at 3rd invitation
Consistent Screeners – – 1.00 (ref)
Late Entrants – – 0.21*** 0.19 to 0.23
Dropouts – – 0.09*** 0.08 to 0.09
Consistent Non-Responders – – 0.01*** 0.01 to 0.01
Listwise deletion was used for the multivariable logistic regression analysis.
* p<.05; ** p<.01; *** p<.001.
†Includes 61-year-olds turning 62 in the same month (n=1).
‡Includes 63-year-olds turning 64 in the same month (n=2).
gFOB, guaiac-based faecal occult blood; IMD, Index of Multiple Deprivation.
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test kit than ‘Previous Non-Responders’ (94.9% vs 92.5%,
p<0.001; table 4). Inadequate screening was much higher
among ‘Previous Non-Responders’ than ‘Previous Responders’
(1.3% vs 0.2%; OR=6.02, 95% CI 4.25 to 8.52, p<0.001;
tables 4 and 8).
In the third invitation round, deﬁnitive test results from just
one test kit were more likely among ‘Consistent Screeners’
(94.7%) than ‘Late Entrants’ (93.5%, p<0.01), ‘Dropouts’
(92.1%, p<0.001) and ‘Consistent Non-Responders’ (90.7%,
p<0.001; table 6). Inadequate screening was more common
among ‘Late Entrants’ (0.5%; OR=2.86, 95% CI 1.64 to 4.96,
p<0.001), ‘Dropouts’ (0.7%; OR=4.38, 95% CI 2.52 to 7.60,
p<0.001) and ‘Consistent Non-Responders’ (2.2%; OR=13.45,
95% CI 8.97 to 20.19, p<0.001) than among ‘Consistent
Screeners’ (0.2%; ref.; tables 6 and 8). ‘Consistent
Non-Responders’ (2.2%) were by far the group most at-risk of
inadequate screening, as they were also signiﬁcantly more likely
to be inadequately screened than ‘Late Entrants’ (0.5%,
p<0.001) and ‘Dropouts’ (0.7%, p<0.001).
Test positivity
Test positivity was 1.2% in the ﬁrst, 1.7% (p<0.001) in the
second, and 1.9% (p<0.001) in the third biennial invitation
rounds (table 2). Within the second round, ‘Previous Responders’
(1.5%) were less likely to test positive than ‘Previous
Non-Responders’ (2.6%, p<0.001; table 4). In the third round,
‘Consistent Screeners’ (1.7%) were less likely to test positive than
‘Late Entrants’ (2.4%, p<0.01), ‘Dropouts’ (2.4%, p<0.01) and
‘Consistent Non-Responders’ (3.3%, p<0.001; table 6).
Follow-up compliance
Compliance with follow-up examinations (colonoscopy or an
alternative test) was 88.9% in the ﬁrst, 88.9% in the second,
and 87.5% in the third biennial invitation rounds; differences in
compliance between rounds were not statistically signiﬁcant
(table 2).
Follow-up compliance in the second invitation round was not
predicted by sex, socioeconomic deprivation, age or screening
history (table 9). In the third round, screening history was the
only signiﬁcant predictor of follow-up compliance. ‘Dropouts’
(80.0%; OR=0.44, 95% CI 0.22 to 0.89, p<0.05) and
‘Consistent Non-Responders’ (79.8%, OR=0.43, 95% CI 0.23
to 0.81, p<0.01) were less likely to comply with follow-up than
‘Consistent Screeners’ (89.9%, ref; tables 6 and 9).
Diagnostic outcomes
CRC was detected among 10.9% of individuals who had under-
gone a follow-up examination in the ﬁrst round, 8.4% in the
second (ns.), and 7.1% the third (p<0.05) biennial invitation
round (table 2). Detection of high-risk and intermediate-risk
adenomas decreased from the ﬁrst (34.1%), to the second
(27.3%, p<0.05) and third (22.2%, p<0.001) rounds. By con-
trast, the proportion of other abnormal ﬁndings increased from
the ﬁrst round (8.2%) to the second (15.4%, p<0.01) and third
(32.0%, p<0.001) rounds. The proportion of low-risk aden-
omas detected was similar (range: 16.3%–18.5%) across the
three rounds.
In the second invitation round, there were no signiﬁcant dif-
ferences in most diagnostic outcomes between ‘Previous
Responders’ and ‘Previous Non-Responders’ (table 4). A mar-
ginal exception were the other abnormal ﬁndings, which were
more common among ‘Previous Non-Responders’ (22.7%) than
among ‘Previous Responders’ (13.2%, p<0.05). Few signiﬁcant
differences in diagnostic outcomes were observed between
screening history subgroups in the third round (table 6). The
cancer detection rate was signiﬁcantly higher among ‘Consistent
Non-Responders’ (11.1%) than ‘Late Entrants’ (2.5%, p<0.05).
Table 4 Uptake in the second biennial screening invitation round
per subgroup by sociodemographics and other outcomes in
percentages with the denominator (n)
Previous
Responders
Previous
Non-Responders
gFOB uptake in the 2nd invitation round
Total 86.55 (34 871) 23.07 (23 677)†***
Women 86.93 (18 777) 23.86 (10 958)
Men 86.11 (16 094) 22.39 (12 719)
IMD 1st quintile 88.35 (7646)‡ 28.43 (4256)§
IMD 2nd quintile 87.72 (7446) 23.43 (4290)
IMD 3rd quintile 86.90 (7247) 24.54 (4478)
IMD 4th quintile 86.01 (6732) 22.17 (4926)
IMD 5th quintile 82.92 (5789) 18.49 (5711)
Age 62–63 at 2nd invitation¶ 86.28 (17 810) 22.34 (12 393)
Age 64–65 at 2nd invitation 87.03 (14 283) 23.62 (9426)
Age 66+ at 2nd invitation 85.88 (2777) 25.24 (1858)
Multiple gFOB testing
% Requiring one test only 94.94 (30 241) 92.52 (5532)†***
% Requiring multiple test kits 5.06 (30 241) 7.48 (5532)†***
% Inadequately screened 0.20 (30 241) 1.27 (5532)†***
FOB positivity
Total 1.50 (30 182) 2.58 (5463)†***
Follow-up compliance
Total 90.27 (452) 84.40 (141)†
Diagnostic outcomes
Cancers 8.09 (408) 9.24 (119)†
High-risk and intermediate-
risk adenomas
27.73 (408) 27.21 (119)†
Low-risk adenomas 17.40 (408) 21.85 (119)†
Other abnormal findings 13.24 (408) 22.69 (119)†*
*p<0.05; ** p<0.01; *** p<0.001.
†Compared with previous responders.
‡IMD scores were not available for 11 individuals.
§IMD scores were not available for 16 individuals.
¶Includes 61-year-olds turning 62 in the same month (n=1), age missing for n=1.
gFOB, guaiac-based faecal occult blood; IMD, Index of Multiple Deprivation.
Table 5 Multivariable logistic regression results of gFOB uptake in
the second biennial screening invitation round per subgroup
Previous Responders
(n=34 859)
Previous
Non-Responders
(n=23 661)
OR 95% CI OR 95% CI
Women 1.00 (ref) 1.00 (ref)
Men 0.93* 0.88 to 0.99 0.92** 0.87 to 0.98
IMD score (0–80) 0.98*** 0.98 to 0.99 0.99*** 0.98 to 0.99
Age at 2nd invitation (62–70)
Age 62–63† 1.00 (ref) 1.00 (ref)
Age 64–65 1.07 1.00 to 1.14 1.07* 1.00 to 1.14
Age 66+ 0.98 0.88 to 1.10 1.18** 1.05 to 1.32
Listwise deletion was used for the multivariable logistic regression analysis.
*p<.05; ** p<.01; *** p<.001.
†Includes 61-year-olds turning 62 in the same month (n=1).
gFOB, guaiac-based faecal occult blood; IMD, Index of Multiple Deprivation.
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Other abnormal ﬁndings were also detected more frequently
among ‘Consistent Screeners’ (33.6%) than ‘Dropouts’ (18.8%,
p<0.05). However, no ﬁrm conclusions should be drawn from
these results as the sample sizes in screening history subgroups
were often very small.
DISCUSSION
Overall gFOB uptake in the NHS BCSP Southern Hub of sub-
jects aged 60–64 years at the time of ﬁrst invitation was 57.4%
in the ﬁrst, 60.9% in the second, and 66.2% in the third bien-
nial invitation rounds. While these ﬁgures show increasing
Table 6 Uptake in the third biennial screening invitation round per subgroup by sociodemographics and other outcomes in percentages with
the denominator (n)
Consistent Screeners Late Entrants Dropouts Consistent Non-Responders
gFOB uptake in the 3rd invitation round
Total 94.53 (29 182) 78.04 (4937)†*** 59.82 (4263)†***/‡*** 14.59 (16 656)†***/‡***/§***
Women 94.63 (15 863) 78.17 (2414) 59.04 (2268) 13.75 (7773)
Men 94.42 (13 319) 77.92 (2523) 60.70 (1995) 15.32 (8883)
IMD 1st quintile 95.56 (6558)¶ 79.29 (1096)†† 62.81 (812)‡‡ 16.70 (2802)§§
IMD 2nd quintile 95.31 (6313) 78.31 (890) 61.39 (834) 18.03 (3023)
IMD 3rd quintile 94.67 (6099) 79.48 (1004) 62.56 (868) 14.87 (3101)
IMD 4th quintile 93.86 (5608) 77.30 (1000) 58.93 (857) 13.63 (3486)
IMD 5th quintile 92.62 (4597) 75.58 (946) 53.77 (889) 11.29 (4233)
Age 64–65 at 3rd invitation¶¶ 94.70 (14 895) 78.36 (2458) 60.85 (2258) 15.25 (8878)
Age 66–67 at 3rd invitation 94.57 (12 015) 77.61 (2032) 59.10 (1670) 14.07 (6560)
Age 68+ at 3rd invitation 93.27 (2272) 78.30 (447) 56.42 (335) 12.56 (1218)
Multiple gFOB testing
% Requiring one test only 94.67 (27 629) 93.54 (3871)†** 92.13 (2568)†***/‡* 90.66 (2484)†***/‡
% Requiring multiple test kits 5.33 (27 629) 6.46 (3871)†** 7.87 (2568)†***/‡* 9.34 (2484)†***/‡
% Inadequately screened 0.16 (27 629) 0.46 (3871)†*** 0.70 (2568)†***/‡ 2.17 (2484)†***/‡***/§***
FOB positivity
Total 1.73 (27 587) 2.36 (3853)†** 2.35 (2550)†**/‡ 3.25 (2430)†***/‡*/§
Follow-up compliance
Total 89.92 (476) 86.81 (91)† 80.00 (60)†*/‡ 79.75 (79)†**/‡/§
Diagnostic outcomes
Cancers 7.01 (428) 2.53 (79)† 10.42 (48)†/‡ 11.11 (63)†/‡*/§
High-risk and intermediate-risk adenomas 21.03 (428) 24.05 (79)† 22.92 (48)†/‡ 26.98 (63)†/‡/§
Low-risk adenomas 16.36 (428) 22.78 (79)† 12.50 (48)†/‡ 11.11 (63)†/‡/§
Other abnormal findings 33.64 (428) 32.91 (79)† 18.75 (48)†*/‡ 30.16 (63)†/‡/§
*p<0.05; **p<0.01; *** p<0.001.
†Compared with consistent screeners.
‡Compared with Late Entrants.
§Compared with Dropouts.
¶IMD scores were not available for 7 individuals.
††IMD score was not available for 1 individual.
‡‡IMD scores were not available for 3 individuals.
§§IMD scores were not available for 11 individuals.
¶¶Includes 63-year-olds turning 64 in the same month (n=2).
gFOB, guaiac-based faecal occult blood; IMD, Index of Multiple Deprivation.
Table 7 Multivariable logistic regression results of gFOB uptake in the third biennial screening invitation round per subgroup
Consistent Screeners
(n=29 175) Late Entrants (n=4936) Dropouts (n=4260)
Consistent Non-Responders
(n=16 645)
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Women 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
Men 0.96 0.87 to 1.06 0.98 0.86 to 1.13 1.06 0.94 to 1.20 1.14** 1.04 to 1.24
IMD score (0–80) 0.98*** 0.98 to 0.99 0.99** 0.99 to 1.00 0.99*** 0.98 to 0.99 0.98*** 0.98 to 0.99
Age at 3rd invitation (63–72)
Age 64–65† 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
Age 66–67 0.97 0.87 to 1.08 0.95 0.82 to 1.09 0.92 0.81 to 1.05 0.91* 0.83 to 1.00
Age 68+ 0.79 0.66 to 0.94 0.99 0.78 to 1.27 0.85 0.67 to 1.07 0.80* 0.67 to 0.96
*p<0.05; **p<0.01; ***p<0.001.
Listwise deletion was used for the multivariable logistic regression analysis.
†Includes 63-year-olds turning 64 in the same month (n=2).
gFOB, guaiac-based faecal occult blood; IMD, Index of Multiple Deprivation.
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uptake among the cohort of subjects ﬁrst invited between
September 2006 and February 2008, this should not be inter-
preted as evidence of a general trend towards higher uptake in
the overall population.
Previous uptake was strongly associated with subsequent
uptake in the second and third invitation round. Uptake in the
ﬁrst invitation round was strongly predictive of subsequent
uptake in the second round (‘Previous Responders’: 86.6% vs
‘Previous Non-Responders’: 23.1%). In the third round, uptake
was highest among ‘Consistent Screeners’ (94.5%), followed by
‘Late Entrants’ (78.0%) and ‘Dropouts’ (59.8%), and lowest
among ‘Consistent Non-Responders’ (14.6%). Socioeconomic
inequalities remained consistent over the three invitation
rounds. Sex inequalities decreased over time because previously
non-responder males were more likely to respond to a second
or third prevalence screening invitation than their female coun-
terparts. Age differences in uptake were minimal across the
three rounds.
These ﬁndings conﬁrm screening history as a major predictor
of subsequent response to screening invitations.5 The results
also show that ‘dropouts’ in the second invitation round follow-
ing participation in the ﬁrst round is associated with lower sub-
sequent uptake in the third round than ‘late entry’ in the second
round following non-response in the ﬁrst round. This suggests
that the ﬁrst experience with screening is pivotal to continued
participation in the screening programme. There is, thus, poten-
tial for behavioural and health service interventions to promote
repeat CRC screening by improving the experience at the time
of the ﬁrst invitation.
Consistent with previous ﬁndings,7 8 this study highlights the
signiﬁcance of ‘Dropouts’ and ‘Late Entrants’ in the screening
programme, as only 44.4% of the initial sample responded to
all three biennial screening invitations. Consistent participation
in gFOB screening is necessary because cancers and adenomas
can bleed intermittently.12 The best quality studies indicate
that sensitivity of gFOB tests is only 30–34% for cancer and
11–19% for adenomas.13 Recent evidence suggests that non-
responders have more advanced cancer staging at diagnosis than
those who have participated in screening.7 ‘Consistent
Screeners’ are also more likely to be diagnosed with a screen-
detected cancer than those who participate irregularly.
The present study also conﬁrmed that the majority of people
invited to participate in CRC screening will eventually accept
the offer.7 8 Consistent with previous NHS pilot studies, the
results conﬁrm that repeated invitations to biennial CRC screen-
ing are clinically important. The proportion of previous non-
responders accepting a second or third prevalence screening
invitation was even higher in our sample (23% and 15%,
respectively) than in the Scottish (15% and 12%) and English
(14% and 10%) pilot programmes.5 6
The frequently cited CRC screening uptake ﬁgures, therefore,
depict a misleading picture of low enthusiasm for CRC screen-
ing in England. Publicity that focuses on low uptake might
convey the message that non-participation in CRC screening is
Table 8 Multivariable logistic regression results of inadequate gFOB screening
1st Biennial invitation round
(n=35 734)
2nd Biennial invitation round
(n=35 766)
3rd Biennial invitation round
(n=36 540)
OR 95% CI OR 95% CI OR 95% CI
Sociodemographics
Women 1.00 (ref) 1.00 (ref) 1.00 (ref)
Men 1.26 0.90 to 1.76 2.09*** 1.45 to 3.02 1.30 0.92 to 1.84
IMD score (0–80) 1.03*** 1.02 to 1.05 1.02** 1.00 to 1.03 1.02** 1.01 to 1.04
Age at 1st invitation (60–64)
Age 60–61 1.00 (ref.) – –
Age 62–63 1.06 0.75 to 1.51 – –
Age 64 1.04 0.55 to 1.96 – –
Age at 2nd invitation (62–70)
Age 62–63† – 1.00 (ref) –
Age 64–65 – 1.05 0.73 to 1.51 –
Age 66+ – 1.13 0.61 to 2.10 –
Age at 3rd invitation (63–72)
Age 64–65‡ – – 1.00 (ref)
Age 66–67 – – 1.10 0.76 to 1.57
Age 68+ – – 1.29 0.69 to 2.39
Previous uptake pattern
Previous uptake patterns at 2nd invitation
Previous Responders – 1.00 (ref) –
Previous Non-Responders – 6.02*** 4.25 to 8.52 –
Previous uptake patterns at 3rd invitation
Consistent Screeners – – 1.00 (ref)
Late Entrants – – 2.86*** 1.64 to 4.96
Dropouts – – 4.38*** 2.52 to 7.60
Consistent Non-Responders – – 13.45*** 8.97 to 20.19
Listwise deletion was used for the multivariable logistic regression analysis.
*p<0.05; ** p<0.01; *** p<0.001.
†Includes 61-year-olds turning 62 in the same month (n=1).
‡Includes 63-year-olds turning 64 in the same month (n=2).
gFOB, guaiac-based faecal occult blood; IMD, Index of Multiple Deprivation.
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‘normal’. Social norms research has shown that people are more
likely to engage with health and environmentally desirable beha-
viours if they believe many other people are engaged with them
as well.14–16 Communicating cumulative uptake in public health
messages might prove more efﬁcacious at increasing population-
based screening than emphasising low uptake rates. The results
also have implications for the planned introduction of a one-off
ﬂexible-sigmoidoscopy (FS) screen at age 55 years. Repeat invi-
tations over a longer time interval could prove a valuable and
practical strategy to boost uptake, in addition to reminders
shortly after the ﬁrst invitation.
Repeated biennial invitations are also shown to reduce sex
inequalities in prevalence screening uptake. Further research
should examine if this is due to men reaching retirement age.
Unlike previous studies showing a simple positive effect of age
on uptake,5 this analysis suggests prevalence screening uptake is
lower for younger invitees, peaks around the middle of the
screen-eligible age range (ie, age 64–66 years) and slightly
decreases again with older age. By contrast with sex inequalities,
socioeconomic inequalities persisted despite repeated invitations
to screening. Socioeconomic inequalities in uptake were less
stark than in the whole of England, likely reﬂecting the relative
afﬂuence of the Southern Hub’s population.4 Considering that
socioeconomic inequalities persist even in this relatively afﬂuent
area, it is likely that repeat invitations in and of themselves will
not redress these health inequalities.
The present study shows that only a minority of subjects failed
to complete further test kits after an invitation for a repeat gFOB
test following a weak positive, spoilt test kit or a technical failure.
However, inadequate screening was more common among those
who had previously not (consistently) participated in screening,
and among subjects from socioeconomically deprived areas. The
negative impact of multiple kit testing on uptake in
‘hard-to-reach’ groups is important given the planned NHS
assessment of Faecal Immunochemical Tests for haemoglobin
(FIT), a test which typically uses a single stool sample. Higher
overall uptake might confer greater overall beneﬁt of FIT over
gFOB testing. Recent ﬁgures from a population-based screening
programme in The Netherlands using FIT showed higher overall
uptake (61–65%) per invitation round.17
Overall, compliance with follow-up examinations (usually col-
onoscopy) was high and showed no signiﬁcant sociodemo-
graphic differences. Previous research has also shown that
sociodemographic differences in colonoscopy uptake are rela-
tively small.18 However, this study demonstrated that an irregu-
lar gFOB screening history was associated with lower
compliance with follow-up. Discrepancies in health outcomes
between regular and irregular screening participants are, there-
fore, due to lower uptake at the stage of the gFOB test as well
as lower compliance with recommended follow-up.
Test positivity increased from 1.2% in the ﬁrst to 1.7% in the
second, and 1.9% in the third biennial invitation round. Higher
Table 9 Multivariable logistic regression results of follow-up compliance
1st Biennial invitation round
(n=424)
2nd Biennial invitation round
(n=593)
3rd Biennial invitation round
(n=706)
OR 95% CI OR 95% CI OR 95% CI
Sociodemographics
Women 1.00 (ref) 1.00 (ref) 1.00 (ref)
Men 0.93 0.49 to 1.75 0.91 0.53 to 1.56 1.07 0.68 to 1.69
IMD score (0–80) 1.00 0.97 to 1.02 0.98 0.96 to 1.00 0.99 0.98 to 1.01
Age at 1st invitation (60–64)
Age 60–61 1.00 (ref) – –
Age 62–63 0.59 0.31 to 1.12 – –
Age 64 0.68 0.21 to 2.16 – –
Age at 2nd invitation (62–70)
Age 62–63† – 1.00 (ref) –
Age 64–65 – 1.27 0.74 to 2.17 –
Age 66+ – 4.26 0.99 to 18.29 –
Age at 3rd invitation (63–72)
Age 64–65‡ – – 1.00 (ref)
Age 66–67 – – 1.17 0.72 to 1.90
Age 68+ – – 0.72 0.34 to 1.54
Previous uptake pattern
Previous uptake patterns at 2nd invitation
Previous Responders – 1.00 (ref) –
Previous Non-Responders – 0.63 0.36 to 1.09 –
Previous uptake patterns at 3rd invitation
Consistent Screeners – – 1.00 (ref)
Late Entrants – – 0.76 0.38 to 1.50
Dropouts – – 0.44* 0.22 to 0.89
Consistent Non-Responders – – 0.43** 0.23 to 0.81
Listwise deletion was used for the multivariable logistic regression analysis.
*p<0.05; **p<0.01; ***p<0.001.
†Includes 61-year-olds turning 62 in the same month (n=1).
‡Includes 63-year-olds turning 64 in the same month (n=2).
IMD, Index of Multiple Deprivation.
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positivity could be partly attributed to the slightly older age of
the cohort in the second and third rounds, and is similar to the
ﬁgures from the Scottish pilot programme which suggests that
the effect of age on uptake is around ∼0.4% between 60–
64year-olds and 65–69-year-olds. Test positivity in the second
and third rounds was higher (∼0.6–1.5%) among individuals
who had declined at least one screening invitation than among
those who had accepted all invitations. This is consistent with
previously reported higher positivity among males and deprived
groups who are over-represented in these ‘hard-to-reach’
groups.19 By contrast with this observation, cancer and high-risk
and intermediate-risk adenoma detection rates among subjects
who had undergone follow-up investigations decreased (slightly)
across the three invitation rounds. Screening history was not
consistently associated with diagnostic outcomes. In conjunction
with the higher positivity rates among those who have declined
at least one screening invitation, this indicates the possibility
that irregular responders are more likely to be diagnosed with
cancer in any given invitation round than those who are consist-
ently screened. However, the sample size in the present study
does not allow for ﬁrm conclusions to be drawn.
Interestingly, the proportion of ‘other abnormal ﬁndings’
(ie, non-cancer-related abnormalities, eg, Crohn’s disease,
ulcerative colitis and diverticulitis) resulting from follow-up
investigations, increased over the three biennial invitation
rounds. The speciﬁc nature of these ﬁndings and the role that
bowel symptoms might play in screening uptake, merits
further investigation in a larger scale, national studies which
can compare irregular responders with consistent responders
and contrast subgroups of irregular responders. It also raises
the question of whether the CRC screening programme
should serve as a route to diagnosis of bowel abnormalities
other than cancer, and if so, how this should be harmonised
with other NHS services.
In conclusion, the present study shows that screening history
is associated with participation in all stages of the CRC screen-
ing process, from overall gFOB screening uptake and inadequate
gFOB screening to compliance with follow-up investigations.
The ﬁrst screening experience seems to play a pivotal role in
inﬂuencing and, therefore, predicting incidence screening
uptake, as ‘Dropout’ in the second biennial invitation round fol-
lowing a prevalence screen was associated with lower uptake in
the third round than delayed prevalence screening in the second
round. The results also show that repeated biennial screening
invitations increase overall uptake and reduce sex inequalities.
By contrast, socioeconomic deprivation was independently asso-
ciated with low gFOB uptake and inadequate screening in all
three invitation rounds. Further research on strategies to engage
non-responders and irregular responders might help promote
regular screening and reduce socioeconomic inequalities in
uptake, thus maximising the protection provided by an orga-
nised screening programme.
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